Esteve’s Tramadol/Celecoxib: US FDA Cites No Major Concerns, But Also No Advantages

 
• By Sue Sutter
  
Metal frame for pouring concrete. The construction of the reinforced concrete frame of the building.
The FDA's review of Esteve's E-58425 reflects the new opioid benefit/risk framework. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers